Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists Read more
Particle Sciences Expands Controlled Substance Capabilities with Approval of DEA Schedule I Read more
Merz Pharma: Xeomin (incobotulinumtoxinA) Receives European Approval for Treatment of Chronic Sialorrhea in Adults Read more
Bayer and Foundation Medicine announce global collaboration to develop NGS-based companion diagnostics in oncology Read more